Compare · ESTA vs INMD

ESTA vs INMD

Side-by-side comparison of Establishment Labs Holdings Inc. (ESTA) and InMode Ltd. (INMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. ESTA focuses on Industrial Specialties, while INMD focuses on Biotechnology: Electromedical & Electrotherapeutic Apparatus.
  • ESTA is the larger of the two at $2.11B, about 2.8x INMD ($762.8M).
  • ESTA has been more active in the news (4 items in the past 4 weeks vs 3 for INMD).
  • INMD has more recent analyst coverage (20 ratings vs 15 for ESTA).
MetricESTAINMD
Company
Establishment Labs Holdings Inc.
InMode Ltd.
Price
-
-
Market cap
$2.11B
$762.8M
1M return
-
-
1Y return
-
-
Industry
Industrial Specialties
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2018
2019
News (4w)
4
3
Recent ratings
15
20
ESTA

Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

INMD

InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.

Latest ESTA

Latest INMD